Variant report
Variant | nsv965628 |
---|---|
Chromosome Location | chr6:12839700-12840200 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532438307 | chr6:12839761-12839762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141479817 | chr6:12839884-12839885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542251902 | chr6:12839911-12839912 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145391045 | chr6:12839925-12839926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187640575 | chr6:12839944-12839945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs193061798 | chr6:12839963-12839964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs137936305 | chr6:12839967-12839968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185882100 | chr6:12839968-12839969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142594971 | chr6:12839976-12839977 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550659852 | chr6:12839982-12839983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114968657 | chr6:12839984-12839985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530156590 | chr6:12840013-12840014 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536523037 | chr6:12840047-12840048 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188804760 | chr6:12840064-12840065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150558314 | chr6:12840068-12840069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1412742 | chr6:12840104-12840105 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs371064462 | chr6:12840107-12840108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1412743 | chr6:12840112-12840113 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs192520838 | chr6:12840117-12840118 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183681113 | chr6:12840133-12840134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573654921 | chr6:12840137-12840138 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542664700 | chr6:12840153-12840154 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551918077 | chr6:12840156-12840157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 21183584 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Breast cancer | 21990379 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:12834200-12839800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr6:12838400-12844800 | Weak transcription | Brain Germinal Matrix | brain |
3 | chr6:12838600-12849400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:12839400-12840000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr6:12839400-12840000 | Enhancers | Brain Anterior Caudate | brain |
6 | chr6:12839600-12841000 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr6:12839800-12840400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr6:12839800-12841000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr6:12840000-12845800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |